Edward P. Jordan

Filings by Edward P. Jordan span 2 companies, the busiest being AMAG Pharmaceuticals Inc. and Humanigen, Inc. In total, 7 filings cover trades dated from 19 August 2014 to 2 March 2022.

On the open market, the record shows 1 purchase worth €26k and 1 sale worth €242k. Taken together, the sales exceed the purchases by €216k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 1 option exercise. So far in 2022, the count stands at 1 purchase and no sales.

The record was last updated on 4 March 2022 with an open-market purchase (€26k) in Humanigen, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.